50% of ‘asthmatics’ don’t really have the disease, say experts

  • News
  • April 15, 2016

New Delhi

When seven-year-old Deepak was rushed to a Delhi hospital a few years back with worsening asthma symptoms, doctors were puzzled. The boy had been on inhalers and even oral steroids, as suggested by a physician in his hometown, Chandigarh, for the last three years but his condition had not improved. “It turned out that the child did not suffer from asthma at all,” said pulmonologist Dr. Arup Basu, who treated Deepak at Sir Ganga Ram Hospital. “The CT scan revealed he had a peanut stuck in the trachea which was causing breathing difficulties.” For three years, the boy had been administered the wrong treatment. Strange as it may sound, Deepak’s is not the only such case of misdiagnosis of asthma. TOI spoke to pulmonologists and medicine experts who said 50% of all patients labelled as asthmatics by primary-level physicians may have wheezing or coughing due to other factors, such as viral infection, allergy or tumour in the upper respiratory tract. Inhalers mustn’t be prescribed without diagnosis and confirmation of asthma. It’s linked to severe side-effects on prolonged use.

  • Related Posts

    • News
    • February 1, 2025
    • 231 views
    Union Budget 2025 pleased Healthcare Leaders except for a Letdown or two

    New Delhi: Healthcare leaders expressed overall satisfaction over Union Budget 2025 except for a letdown or two. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), though appreciated…

    ‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

    New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

    Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

    Sun-Ranbaxy $4 billion merger completed

    Sun-Ranbaxy $4 billion merger completed

    Dr Reddy’s gets over Rs 2,395 crore show cause notice from I-T authority

    Dr Reddy’s gets over Rs 2,395 crore show cause notice from I-T authority

    ‘Made in India’ Stents win major victory against Import Lobby

    ‘Made in India’ Stents win major victory against Import Lobby